← Back to Search

Brief Psychotherapy + Mobile App for Suicide Prevention

N/A
Recruiting
Led By Evan Kleiman
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up beginning of study and end-of-study, approximately four weeks post discharge
Awards & highlights

Study Summary

This trial is testing a new intervention to reduce the risk of suicide, particularly in the period immediately after discharge from inpatient psychiatric care. It hopes to make treatments accessible and effective during a suicide crisis.

Who is the study for?
This trial is for adults over 18 who were admitted to certain hospital units due to suicide risk, can speak and write English fluently, and own a smartphone with internet. It aims to help those at high risk for suicide after they leave the hospital.Check my eligibility
What is being tested?
The study tests an innovative intervention combining brief psychotherapy with a mobile app designed to be easily used and effective during periods of distress, particularly following psychiatric discharge.See study design
What are the potential side effects?
Since this trial involves psychotherapy and use of a mobile app, traditional physical side effects are not applicable. However, participants may experience emotional discomfort or distress as part of therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~overall changes in momentary self-reported intensity of suicidal urges (on a 11-point scale up to 4x/ day via ecological momentary assessment) from pre- to post-emi use, across the study period, which is approximately four weeks post discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and overall changes in momentary self-reported intensity of suicidal urges (on a 11-point scale up to 4x/ day via ecological momentary assessment) from pre- to post-emi use, across the study period, which is approximately four weeks post discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-efficacy for managing negative emotion
Suicidal thoughts

Trial Design

1Treatment groups
Experimental Treatment
Group I: Unified ProtocolExperimental Treatment1 Intervention
Unified Protocol-based treatment, with three sessions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Unified Protocol
2020
N/A
~390

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,192 Total Patients Enrolled
Massachusetts General HospitalOTHER
2,935 Previous Clinical Trials
13,198,601 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,669 Total Patients Enrolled

Media Library

Unified Protocol Clinical Trial Eligibility Overview. Trial Name: NCT05867316 — N/A
Suicide and Self-Harm Research Study Groups: Unified Protocol
Suicide and Self-Harm Clinical Trial 2023: Unified Protocol Highlights & Side Effects. Trial Name: NCT05867316 — N/A
Unified Protocol 2023 Treatment Timeline for Medical Study. Trial Name: NCT05867316 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to take part in this research?

"According to clinicaltrials.gov, this medical study has ceased its search for participants - the posting was initially published on June 1st 2023 and last amended on May 17th 2023. Nevertheless, 246 other trials are currently welcoming new enrollees."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Supplementing Brief Psychotherapy With a Mobile App
Evan M. Kleiman, Ph.D. 2023. "Supplementing Brief Psychotherapy With a Mobile App". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05867316.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top